ESC 365 - Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

ESC Premium Access

Combination therapy with renin-angiotensin system inhibitors and statins is associated with reduced incidence of new-onset atrial fibrillation in hypertensive patients

Session: Hypertension and Atrial Fibrillation

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Speaker: Doctor T. Horio (Higashi-Osaka, JP)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Takeshi Horio

Ishikiriseiki Hospital, Higashi-Osaka (Japan)

0 follower

3 more presentations in this session

Fatal attraction: hypertension and atrial fibrillation - Current knowledge

Speaker: Professor A. Manolis (Athens, GR)

Long-term systolic blood pressure trajectories predict risk of incident atrial fibrillation in a general population cohort study

Speaker: Doctor E. Sharashova (Tromso, NO)

Efficacy and safety of edoxaban vs warfarin stratified by achieved blood pressure in 19,754 patients with hypertension in ENGAGE AF-TIMI 48

Speaker: Professor S. Park (Seoul, KR)

Access the full session

Hypertension and Atrial Fibrillation

Speakers: Doctor T. Horio, Professor A. Manolis, Doctor E. Sharashova, Professor S. Park

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources